Volume 112, Issue 8 pp. 1510-1511
Letter to the Editor
Free Access

Reply to Osborne & Serdarevic (2017): Potential impact of exposure definition when examining non-medical use of prescription opioids among US veterans

Geetanjoli Banerjee

Geetanjoli Banerjee

Department of Epidemiology, Brown School of Public Health, Providence, RI, USA

Search for more papers by this author
E. Jennifer Edelman

E. Jennifer Edelman

Department of Internal Medicine, Yale School of Medicine, Yale University, New Haven, CT, USA

Yale Center for Interdisciplinary Research on AIDS, Yale School of Public Health, Yale University, New Haven, CT, USA

Search for more papers by this author
Declan T. Barry

Declan T. Barry

Yale University School of Medicine, New Haven, CT, USA

APT Foundation Pain Treatment Services, New Haven, CT, USA

Search for more papers by this author
William C. Becker

William C. Becker

Pain Research, Informatics, Multi-morbidities and Education (PRIME) Center, VA, Connecticut Healthcare System, West Haven, CT, USA

Search for more papers by this author
Magdalena Cerdá

Magdalena Cerdá

Department of Emergency Medicine, University of California, Davis, Sacramento, CA, USA

Search for more papers by this author
Stephen Crystal

Stephen Crystal

Institute for Health, Health Care Policy, and Aging Research, Rutgers University, New Brunswick, NJ, USA

Search for more papers by this author
Julie R. Gaither

Julie R. Gaither

Yale Center for Interdisciplinary Research on AIDS, Yale School of Public Health, Yale University, New Haven, CT, USA

Yale Center for Medical Informatics, Yale School of Medicine, New Haven, CT, USA

Department of Emergency Medicine, University of California, Davis, Sacramento, CA, USA

Search for more papers by this author
Adam J. Gordon

Adam J. Gordon

Center for Health Equity Research and Promotion (CHERP) and Mental Illness Research Education and Clinical Center (MIRECC), VA Pittsburgh Healthcare System and University of Pittsburgh, Pittsburgh, PA, USA

Search for more papers by this author
Kirsha S. Gordon

Kirsha S. Gordon

VA Connecticut Healthcare System, West Haven, CT, USA

Search for more papers by this author
Robert D. Kerns

Robert D. Kerns

Pain Research, Informatics, Multi-morbidities and Education (PRIME) Center, VA, Connecticut Healthcare System, West Haven, CT, USA

Departments of Psychiatry, Neurology and Psychology, Yale University, New Haven, CT, USA

Search for more papers by this author
Silvia S. Martins

Silvia S. Martins

Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA

Search for more papers by this author
David A. Fiellin

David A. Fiellin

Department of Internal Medicine, Yale School of Medicine, Yale University, New Haven, CT, USA

Yale Center for Interdisciplinary Research on AIDS, Yale School of Public Health, Yale University, New Haven, CT, USA

Search for more papers by this author
Brandon D. L. Marshall

Corresponding Author

Brandon D. L. Marshall

Department of Epidemiology, Brown School of Public Health, Providence, RI, USA

Search for more papers by this author
First published: 12 June 2017

We thank Ms Osborne and Ms Serdarevic for their letter 1 and appreciate their comments regarding our paper, which demonstrated an independent association between non-medical use of prescription opioids (NMUPO) and heroin initiation among US veterans 2. As they note in their letter, we acknowledged that a limitation of our study was the fact that there were two different versions of the survey instrument, leading us to define non-medical use based on responses to an item referencing ‘any use of prescription opioids in the past 12 months’, for the first two waves of the survey. In subsequent waves, we adopted a definition of non-medical use set forth by the National Survey on Drug Use and Health (NSDUH), which defines NMUPO as ‘using a prescription pain reliever even once, that was not prescribed for you, or that you took for the experience or feeling it caused’ 3. While we agree with the authors that the former definition may have included some prescribed use, we would like to clarify that this item was placed among a panel of questions asking about other illicit substance use (e.g. cocaine, methamphetamine and heroin). Therefore, we believe this context encouraged study participants to report illicit prescription opioid use, not the use of opioids as prescribed by their health-care providers.

Ms Osborne and Ms Serdarevic suggested that we re-run our analysis using only the three waves of surveys in which the definition of NMUPO was consistent with NSDUH's. However, we are concerned that the resulting estimate would be biased as a result of selection effects. The Veterans Aging Cohort Study (VACS) was conducted during a 10-year period, from 2002 to 2012, and the majority of heroin initiation events occurred after the first two waves of the survey. As such, the hazard ratio for NMUPO calculated using only the last three survey waves would have built-in selection bias, because those VACS participants who were most susceptible to initiating heroin use as a result of NMUPO may have done so earlier during the study period, a concept known as ‘depletion of the susceptibles’ 4. Additionally, as the precision of the hazard ratio depends upon the observed number of events (in this case heroin initiation events), when the event rates are low, the resulting confidence interval can be quite large 5. Unfortunately, there were not sufficient events to assess the relationship between NMUPO and heroin initiation stratified by survey wave.

In conclusion, we agree that difference in definitions of NMUPO used in the analysis is a limitation of our study. In our work and in others, further research is needed to understand more clearly the validity of various definitions of NMUPO, and how they relate to diverse motivations for the non-medical use of prescription opioids in different populations 6.

Declaration of interest

None.

    The full text of this article hosted at iucr.org is unavailable due to technical difficulties.